Arrestins as regulators of kinases and phosphatases

Progress in Molecular Biology and Translational Science

Volumn 118, Issue , 2013, Pages 115-147

  Luttrell, Louis M ^a,b   Miller, William E ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879088145     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394440-5.00005-X     Document Type: Chapter

References (120)

1. S.S. Ferguson Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling Pharmacol Rev 53 2001 1 24
2. O.B. Goodman Jr., J.G. Krupnick, and F. Santini Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor Nature 383 1996 447 450
3. S.A. Laporte, R.H. Oakley, and J. Zhang The beta2-adrenergic receptor/beta arrestin complex recruits the clathrin adaptor AP-2 during endocytosis Proc Natl Acad Sci USA 96 1999 3712 3717
4. L.M. Luttrell, B.E. Hawes, T. van Biesen, D.K. Luttrell, T.J. Lansing, and R.J. Lefkowitz Role of c-Src in G protein-coupled receptor- and Gβγ subunit-mediated activation of mitogen activated protein kinases J Biol Chem 271 1996 19443 19450
5. T. van Biesen, B.E. Hawes, and D.K. Luttrell Receptor-tyrosine-kinase- and Gβγ-mediated MAP kinase activation by a common signalling pathway Nature 376 1995 781 784
6. L.M. Luttrell, S.S.G. Ferguson, and Y. Daaka β-Arrestin-dependent formation of β2 adrenergic receptor/Src protein kinase complexes Science 283 1999 655 661
7. S. Galandrin, and M. Bouvier Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy Mol Pharmacol 70 2006 1575 1584
8. S. Maudsley, B. Martin, and L.M. Luttrell Perspectives in pharmacology: the origins of diversity and specificity in G protein-coupled receptor signaling J Pharmacol Exp Ther 314 2005 485 494
9. L.M. Luttrell Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors Mol Biotechnol 39 2008 239 264
10. L.M. Luttrell, and D. Gesty-Palmer Beyond desensitization: physiological relevance of arrestin-dependent signaling Pharmacol Rev 62 2010 305 330
11. K.A. DeFea, Z.D. Vaughn, E.M. O'Bryan, D. Nishijima, O. Dery, and N.W. Bunnett The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex Proc Natl Acad Sci USA 97 2000 11086 11091
12. J. Barlic, J.D. Andrews, and A.A. Kelvin Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI Nat Immunol 1 2000 227 233
13. P.H. McDonald, C.W. Chow, and W.E. Miller Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3 Science 290 2000 1574 1577
14. K.A. DeFea, J. Zalevsky, M.S. Thoma, O. Dery, R.D. Mullins, and N.W. Bunnett Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2 J Cell Biol 148 2000 1267 1281
15. L.M. Luttrell, F.L. Roudabush, and E.W. Choy Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds Proc Natl Acad Sci USA 98 2001 2449 2454
16. S.K. Shenoy, P.H. McDonald, T.A. Kohout, and R.J. Lefkowitz Regulation of receptor fate by ubiquitination of activated β2-adrenergic receptor and β-arrestin Science 294 2001 1307 1313
17. S.J. Perry, G.S. Baillie, and T.A. Kohout Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins Science 298 2002 834 836
18. C.D. Nelson, S.J. Perry, D.S. Regier, S.M. Prescott, M.K. Topham, and R.J. Lefkowitz Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins Science 315 2007 663 666
19. D.S. Witherow, T.R. Garrison, W.E. Miller, and R.J. Lefkowitz Beta-arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha Proc Natl Acad Sci USA 101 2004 8603 8607
20. M. Bhattacharya, P.H. Anborgh, and A.V. Babwah Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization Nat Cell Biol 4 2002 547 555
21. M. Zoudilova, P. Kumar, L. Ge, P. Wang, G.M. Bokoch, and K.A. DeFea Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2 J Biol Chem 282 2007 20634 20646
22. J.M. Beaulieu, T.D. Sotnikova, and W.D. Yao Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc Natl Acad Sci USA 101 2004 5099 5104
23. J.M. Beaulieu, T.D. Sotnikova, S. Marion, R.J. Lefkowitz, R.R. Gainetdinov, and M.G. Caron An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior Cell 122 2005 261 273
24. D. Gesty-Palmer, and L.M. Luttrell Refining efficacy: exploiting functional selectivity for drug discovery Adv Pharmacol 62 2011 79 107
25. A. Tohgo, K.L. Pierce, E.W. Choy, R.J. Lefkowitz, and L.M. Luttrell β-Αrrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK mediated transcription following angiotensin AT1a receptor stimulation J Biol Chem 277 2002 9429 9436
26. W.R. Burack, and A.S. Shaw Signal transduction: hanging on a scaffold Curr Opin Cell Biol 12 2000 211 216
27. E.A. Elion The Ste5p scaffold J Cell Sci 114 2001 3967 3978
28. M.G. Scott, E. Le Rouzic, and A. Perianin Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2 J Biol Chem 277 2002 37693 37701
29. P. Wang, Y. Wu, X. Ge, L. Ma, and G. Pei Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus J Biol Chem 278 2003 11648 11653
30. M. Breitman, S. Kook, and L.E. Gimenez Silent scaffolds: inhibition of c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant J Biol Chem 287 2012 19653 19664
31. A. Tohgo, E.W. Choy, and D. Gesty-Palmer The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation J Biol Chem 278 2003 6258 6267
32. H. Wei, S. Ahn, and S.K. Shenoy Independent G protein and beta-Arrestin2 mediated activation of ERK by angiotensin Proc Natl Acad Sci USA 100 2003 10782 10787
33. R.T. Kendall, and L.M. Luttrell Diversity in β-Arrestin Function Cell Mol Life Sci 66 2009 2953 2973
34. S. Ahn, S.K. Shenoy, H. Wei, and R.J. Lefkowitz Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor J Biol Chem 279 2004 35518 35525
35. S.M. DeWire, J. Kim, E.J. Whalen, S. Ahn, M. Chen, and R.J. Lefkowitz Beta-arrestin-mediated signaling regulates protein synthesis J Biol Chem 283 2008 10611 10620
36. X. Song, E.V. Gurevich, and V.V. Gurevich Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites J Neurochem 103 2007 1053 1062
37. X. Song, S. Coffa, H. Fu, and V.V. Gurevich How does arrestin assemble MAPKs into a signaling complex? J Biol Chem 284 2009 685 695
38. S. Coffa, M. Breitman, and S.M. Hanson The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation PLoS One 6 2011 e28723
39. F. Jafri, H.M. El-Shewy, M.H. Lee, M. Kelly, D.K. Luttrell, and L.M. Luttrell Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome" J Biol Chem 281 2006 19346 19357
40. D. Stokoe, S.G. Macdonald, K. Cadwallader, M. Symons, and J.F. Hancock Activation of Raf as a result of recruitment to the plasma membrane Science 264 1994 1463 1467
41. S. Terrillon, and M. Bouvier Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes EMBO J 23 2004 3950 3961
42. X. Song, D. Raman, E.V. Gurevich, S.A. Vishnivetskiy, and V.V. Gurevich Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm J Biol Chem 281 2006 21491 21499
43. J. Seo, E.L. Tsakem, M. Breitman, and V.V. Gurevich Identification of arrestin-3-specific residues necessary for JNK3 kinase activation J Biol Chem 286 2011 27894 27901
44. W.E. Miller, P.H. McDonald, S.F. Cai, M.E. Field, R.J. Davis, and R.J. Lefkowitz Identification of a motif in the carboxyl terminus of beta-arrestin2 responsible for activation of JNK3 J Biol Chem 276 2001 27770 27777
45. S.K. Shenoy, and R.J. Lefkowitz Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes J Biol Chem 280 2005 15315 15324
46. M.-H. Lee, H.M. El-Shewy, D.K. Luttrell, and L.M. Luttrell Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription J Biol Chem 283 2008 2088 2097
47. F.-T. Lin, W.E. Miller, L.M. Luttrell, and R.J. Lefkowitz Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases J Biol Chem 274 1999 15971 15974
48. B. Zimmerman, M. Simaan, M.-H. Lee, L.M. Luttrell, and S.A. Laporte c-Src-mediated phosphorylation of AP-2 reveals a general mechanism for receptors internalizing through the clathrin pathway Cell Signal 21 2009 103 110
49. L. Ge, Y. Ly, M. Hollenberg, and K. DeFea A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis J Biol Chem 278 2003 34418 34426
50. A.C. Holloway, H. Qian, and L. Pipolo Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors Mol Pharmacol 61 2002 768 777
51. K. Xiao, J. Sun, and J. Kim Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR) Proc Natl Acad Sci USA 107 2010 15299 15304
52. G.L. Christensen, C.D. Kelstrup, and C. Lyngsø Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists Mol Cell Proteomics 9 2010 1540 1553
53. W. Richter, P. Day, and R. Agrawal Signaling from beta1- and beta2-adrenergic receptors is defined by differential interactions with PDE4 EMBO J 27 2008 384 393
54. B. Luan, Z. Zhang, Y. Wu, J. Kang, and G. Pei Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation EMBO J 24 2005 4237 4246
55. H. Gao, Y. Sun, and Y. Wu Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways Mol Cell 14 2004 303 317
56. H. Fan, L.M. Luttrell, G.E. Tempel, J.J. Senn, P.V. Halushka, and J.A. Cook β-Arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression Mol Immunol 44 2007 3092 3099
57. J.M. Beaulieu, S. Marion, and R.M. Rodriguiz A beta-arrestin 2 signaling complex mediates lithium action on behavior Cell 132 2008 125 136
58. R.T. Kendall, E.G. Strungs, and S.M. Rachidi The beta-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1, Ile4, Ile8]angiotensin II regulates a robust G protein-independent signaling network J Biol Chem 286 2011 19880 19891
59. W.E. Miller, S. Maudsley, S. Ahn, K.D. Khan, L.M. Luttrell, and R.J. Lefkowitz Beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis J Biol Chem 275 2000 11312 11319
60. P. Penela, A. Elorza, S. Sarnago, and F. Mayor Jr. Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2 EMBO J 20 2001 5129 5138
61. C. Galet, and M. Ascoli Arrestin-3 is essential for the activation of Fyn by the luteinizing hormone receptor (LHR) in MA-10 cells Cell Signal 20 2008 1822 2829
62. T. Noma, A. Lemaire, and S.V. Naga Prasad Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection J Clin Invest 117 2007 2445 2458
63. K. Seta, M. Nanamori, J.G. Modrall, R.R. Neubig, and J. Sadoshima AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs J Biol Chem 277 2002 9268 9277
64. D. Gesty-Palmer, H. El Shewy, T.A. Kohout, and L.M. Luttrell Beta-arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts J Biol Chem 280 2005 32157 32167
65. Y. Sun, Z. Cheng, L. Ma, and G. Pei Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation J Biol Chem 277 2002 49212 49219
66. M.R. Bruchas, T.A. Macey, J.D. Lowe, and C. Chavkin Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes J Biol Chem 281 2006 18081 18089
67. M. Zhao, A. Wimmer, K. Trieu, R.G. Discipio, and I.U. Schraufstatter Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2 J Biol Chem 279 2004 49259 49267
68. R. Goel, P.J. Phillips-Mason, D.M. Raben, and J.J. Baldassare Alpha-thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression J Biol Chem 277 2002 18640 18648
69. M.C. Yu, L.L. Su, and L. Zou An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells Nat Immunol 9 2008 898 907
70. P. Wang, and K.A. DeFea Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase Biochemistry 45 2006 9374 9385
71. C.D. Nelson, J.J. Kovacs, K.N. Nobles, E.J. Whalen, and R.J. Lefkowitz Beta-arrestin scaffolding of phosphatidylinositol 4-phosphate 5-kinase Ialpha promotes agonist-stimulated sequestration of the beta2-adrenergic receptor J Biol Chem 283 2008 21093 21101
72. E.J. Whalen, S. Rajagopal, and R.J. Lefkowitz Therapeutic potential of β-arrestin- and G protein-biased agonists Trends Mol Med 17 2011 126 139
73. A.J. Ghalayini, N. Desai, K.R. Smith, R.M. Holbrook, M.H. Elliott, and H. Kawakatsu Light-dependent association of Src with photoreceptor rod outer segment membrane proteins in vivo J Biol Chem 277 2002 1469 1476
74. S. Ahn, S. Maudsley, L.M. Luttrell, R.J. Lefkowitz, and Y. Daaka Src-mediated tyrosine phosphorylation of dynamin is required for beta2-adrenergic receptor internalization and mitogen-activated protein kinase signaling J Biol Chem 274 1999 1185 1188
75. S. Ahn, J. Kim, and C.L. Lucaveche Src-dependent tyrosine phosphorylation regulates dynamin self-assembly and ligand-induced endocytosis of the epidermal growth factor receptor J Biol Chem 277 2002 26642 26651
76. Y. Werbonat, N. Kleutges, K.H. Jakobs, and C.J. van Koppen Essential role of dynamin in internalization of M2 muscarinic acetylcholine and angiotensin AT1A receptors J Biol Chem 275 2000 21969 21974
77. D. Fessart, M. Simaan, and S.A. Laporte c-Src regulates clathrin adapter protein 2 interaction with beta-arrestin and the angiotensin II type 1 receptor during clathrin-mediated internalization Mol Endocrinol 19 2005 491 503
78. D. Fessart, M. Simaan, and B. Zimmerman Src-dependent phosphorylation of beta2-adaptin dissociates the beta-arrestin-AP-2 complex J Cell Sci 120 2007 1723 1732
79. T. Imamura, J. Huang, and S. Dalle Beta-arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport J Biol Chem 276 2001 43663 43667
80. M. Yang, H. Zhang, T. Voyno-Yasenetskaya, and R.D. Ye Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activation Mol Pharmacol 64 2003 447 455
81. L.M. Luttrell Location, Location. Location. Spatial and temporal regulation of MAP kinases by G protein-coupled receptors J Mol Endo 30 2003 117 126
82. G. Pearson, F. Robinson, and T. Beers Gibson Mitogen-activated protein (MAP) kinase pathways: regulation and physiologic functions Endocr Rev 22 2001 153 183
83. J.S. Gutkind The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades J Biol Chem 273 1998 1839 1842
84. S.M. Hanson, W.M. Cleghorn, and D.J. Francis Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity J Mol Biol 368 2007 375 387
85. S.K. Shenoy, M.T. Drake, and C.D. Nelson Beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor J Biol Chem 281 2006 1261 1273
86. D. Gesty-Palmer, M. Chen, and E. Reiter Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation J Biol Chem 281 2006 10856 10864
87. S.K. Shenoy, L.S. Barak, and K. Xiao Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation J Biol Chem 282 2007 29549 29562
88. J. Kim, S. Ahn, and X.R. Ren Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling Proc Natl Acad Sci USA 102 2005 1442 1447
89. X.R. Ren, E. Reiter, S. Ahn, J. Kim, W. Chen, and R.J. Lefkowitz Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor Proc Natl Acad Sci USA 102 2005 1448 1453
90. K.N. Nobles, K. Xiao, and S. Ahn Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin Sci Signal 4 2011 ra51
91. S. Ahn, J. Kim, M.R. Hara, X.R. Ren, and R.J. Lefkowitz Beta-arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation J Biol Chem 284 2009 8855 8865
92. C. Tournier, P. Hess, and D.D. Yang Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288 2000 870 874
93. C.Y. Kuan, A.J. Whitmarsh, and D.D. Yang A critical role of neural-specific JNK3 for ischemic apoptosis Proc Natl Acad Sci USA 100 2003 15184 15189
94. A. Lin, and K.A. Defea β-Arrestin-kinase scaffolds: turn them on or turn them off? Wiley Interdiscip Rev Syst Biol Med 5 2013 231 241
95. T.L. Zhang, J.L. Fu, Z. Geng, J.J. Yang, and X.J. Sun The neuroprotective effect of losartan through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat hippocampal CA1 region CNS Neurosci Ther 18 2012 981 987
96. J.W. McAlees, and V.M. Sanders Hematopoietic protein tyrosine phosphatase mediates beta2-adrenergic receptor-induced regulation of p38 mitogen-activated protein kinase in B lymphocytes Mol Cell Biol 29 2009 675 686
97. N.J. McLaughlin, A. Banerjee, and M.R. Kelher Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation J Immunol 176 2006 7039 7050
98. X. Yang, G. Zhou, and T. Ren β-Arrestin prevents cell apoptosis through pro-apoptotic ERK1/2 and p38 MAPKs and anti-apoptotic Akt pathways Apoptosis 17 2012 1019 1026
99. Y. Wang, Y. Tang, L. Teng, Y. Wu, X. Zhao, and G. Pei Association of beta-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling Nat Immunol 7 2006 139 147
100. F. Basher, H. Fan, and B. Zingarelli Beta-arrestin 2: a negative regulator of inflammatory responses in polymorphonuclear leukocytes Int J Clin Exp Med 1 2008 32 41
101. E.C. Finger, N.Y. Lee, H.J. You, and G.C. Blobe Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation J Biol Chem 283 2008 34808 34818
102. K. Mythreye, and G.C. Blobe The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42 Proc Natl Acad Sci USA 106 2009 8221 8226
103. H.J. You, T. How, and G.C. Blobe The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2 Carcinogenesis 30 2009 1281 1287
104. F.T. Lin, W. Chen, S. Shenoy, M. Cong, S.T. Exum, and R.J. Lefkowitz Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors Biochemistry 41 2002 10692 10699
105. B. Masri, A. Salahpour, and M. Didriksen Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics Proc Natl Acad Sci USA 105 2008 13656 13661
106. C.J. Hupfeld, J.L. Resnik, S. Ugi, and J.M. Olefsky Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptors J Biol Chem 280 2005 1016 1023
107. J.A. Pitcher, E.S. Payne, C. Csortos, A.A. DePaoli-Roach, and R.J. Lefkowitz The G-protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity Proc Natl Acad Sci USA 92 1995 8343 8347
108. K.M. Krueger, Y. Daaka, J.A. Pitcher, and R.J. Lefkowitz The role of sequestration in G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification J Biol Chem 272 1997 5 8
109. D. Abraham, K. Podar, and M. Pacher Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation J Biol Chem 275 2000 22300 22304
110. D.G. Adams, R.L. Coffee Jr., H. Zhang, S. Pelech, S. Strack, and B.E. Wadzinski Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes J Biol Chem 280 2005 42644 42654
111. B. Zhou, Z.X. Wang, Y. Zhao, D.L. Brautigan, and Z.Y. Zhang The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases J Biol Chem 277 2002 31818 31825
112. A.M. Silverstein, C.A. Barrow, A.J. Davis, and M.C. Mumby Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits Proc Natl Acad Sci USA 99 2002 4221 4226
113. L.M. Machesky Cell motility: complex dynamics at the leading edge Curr Biol 7 1997 R164 R167
114. A.M. Fong, R.T. Premont, R.M. Richardson, Y.R. Yu, R.J. Lefkowitz, and D.D. Patel Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice Proc Natl Acad Sci USA 99 2002 7478 7483
115. A.M. Aragay, M. Mellado, and J.M. Frade Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2 Proc Natl Acad Sci USA 95 1998 2985 2990
116. L. Ge, S.K. Shenoy, R.J. Lefkowitz, and K. DeFea Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2 J Biol Chem 279 2004 55419 55424
117. W.G. Barnes, E. Reiter, J.D. Violin, X.R. Ren, G. Milligan, and R.J. Lefkowitz Beta-arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation J Biol Chem 280 2005 8041 8050
118. D.L. Hunton, W.G. Barnes, and J. Kim Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis Mol Pharmacol 67 2005 1229 1236
119. M.G. Scott, V. Pierotti, and H. Storez Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins Mol Cell Biol 26 2006 3432 3445
120. M. Lodeiro, B.O. Alén, and C.S. Mosteiro The SHP-1 protein tyrosine phosphatase negatively modulates Akt signaling in the ghrelin/GHSR1a system Mol Biol Cell 22 2011 4182 4191